Clinical and Translational Allergy

Papers
(The TQCC of Clinical and Translational Allergy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
44
42
Correction to “Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety”34
Self‐reported accidental allergic reactions among patients with challenge‐verified food allergy34
Distinct Phenotypes of Peripheral Innate Lymphoid Cells and T Cells in Type 2 and Non‐Type 2 Asthma32
Lung Acetate Levels Decline in Correlation With Increased Type 2 Allergic Markers in a House Dust Mite Allergic Mouse Model28
Evaluation of Diagnosis, Cross‐Reactivity, and Risk Factors in Pediatric Patients With Macrolide Allergy26
Role of Disulfidptosis in the Local Inflammatory Response of Atopic Dermatitis26
Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps24
A Novel Cell Culture System to Improve MRGPRX2 Research in Human Skin Mast Cells24
Sensitivity to change and minimal clinically important difference of the angioedema control test24
Eczema in early childhood increases the risk of allergic multimorbidity22
Epicutaneous immunotherapy for food allergy: A systematic review and meta‐analysis22
21
Issue Information20
Issue Information20
Issue Information19
Predicting Blomia tropicalis allergens using a multiomics approach19
MASK‐air® real‐world data in respiratory allergy in old‐age adults18
The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge18
Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme18
18
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis17
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project17
Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app17
Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema17
Physical Exercise Improves Symptomatic Dermographism16
Charcot‐Leyden crystals in tissues15
Issue Information15
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study15
14
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety14
Anaphylaxis management in a French pediatric emergency department: Lessons from the ANA‐PED study14
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)14
Evaluation of the Quality and Reliability of ChatGPT‐4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality Assessment14
14
Ethnic differences in depression and anxiety among adults with atopic eczema: Population‐based matched cohort studies within UK primary care13
13
Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps13
Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease13
Why the role of mHealth in allergy diagnosis and treatment adherence cannot be overlooked13
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response13
Breath of relief: Transforming pediatric asthma care with telemedicine‐guided exercises13
13
Adult‐Onset Compared to Childhood‐Onset Asthma: Multifaceted Symptoms, Comorbidity, and Healthcare Burden13
Asthma is associated with increased severity and duration of rhinitis: A study with the Allergic Rhinitis and its Impact on Asthma classes in the Constances cohort12
Safety and Efficacy of Very Low‐Dose Multi‐Nut Oral Immunotherapy in Children12
A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma12
Contact allergens in moisturizers in preventative emollient therapy – A systematic review12
Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10‐Year Cohort Study12
Reference Values and Determinants of Fractional Exhaled Nitric Oxide in a Representative Adult Population in Western Sweden12
Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis12
Real‐Life Safety of Japanese Cedar Pollen Sublingual Immunotherapy Tablets: A Post‐Marketing Survey11
Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis11
Food allergy: What are people looking for? An infodemiology study11
Natural Killer Cell Dysfunction Causes Eosinophil Accumulation in Chronic Rhinosinusitis With Nasal Polyps11
11
10
Issue Information10
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey10
Risk assessment behaviour when eating out in adults with food hypersensitivity10
Adverse events for biologics in patients with CRSwNP: A meta‐analysis10
Suppressed pediatric asthma hospitalizations during the COVID‐19 pandemic in Japan, from a national survey10
T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab10
Association between telomere length and atopic dermatitis among school‐age children10
Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling10
Variability of Diagnostic Outcomes in Nasal Allergen Challenge: The Role of Combined Subjective and Objective Indicators10
Issue Information9
Aerobiology matters: Why people in the community access pollen information and how they use it9
Issue Information9
Issue Information9
Dietary fibre in relation to asthma, allergic rhinitis and sensitization from childhood up to adulthood9
Advances in the Gut‐Lung Axis and Bronchial Asthma: From Mechanisms to Therapeutic Potential9
9
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities9
9
Inflammatory related plasma proteins involved in acute preschool wheeze9
Role of impulse oscillometry in chronic obstructive pulmonary disease and asthma‐chronic obstructive pulmonary disease overlap9
9
Issue Information9
Real‐world drug use in asthma, chronic obstructive pulmonary disease, rhinitis, cough, and cold in Finland from 1990 to 2021: Association with reduced disease burden8
Milk Ladder Efficacy and Safety in IgE‐Mediated Cow's Milk Allergy: A Systematic Review and Meta‐Analysis of Controlled Studies8
Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity8
Work‐related dysphonia in subjects with occupational asthma is associated with neutrophilic airway inflammation8
Next Generation Sequencing of Genes With Epigenetic Alterations in Mastocytosis8
Gut microbial alteration in chronic spontaneous urticaria unresponsive to second generation antihistamines and its correlation with disease characteristics‐ a cross‐sectional case‐control study8
Effect of infant viral respiratory disease on childhood asthma in a non‐industrialized setting8
Socioeconomic status and different forms of rhinitis in Swedish adults8
Advent of oral medications for the treatment of hereditary angioedema8
Issue Information8
Associations with food allergy‐related psychological distress in a global sample of adults, children and caregivers7
The present and future of digital health, digital medicine, and digital therapeutics for allergic diseases7
INMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia7
Is there a role of genetics in acute and chronic urticaria—A systematic review and meta‐analysis7
Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One‐Bag Protocols7
The impact of COVID‐19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database7
The efficacy and safety of oral microecological agents as add‐on therapy for atopic dermatitis: A systematic review and meta‐analysis of randomized clinical trials7
Prevalence, predictors, and clinical relevance of α‐gal sensitization in patients with chronic urticaria7
High‐risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system7
Issue Information7
Clinical review: The suggested management pathway for urticaria in primary care7
Prevalence of sensitization to molecular food allergens in Europe: A systematic review7
Lack of detection of aluminium‐reactive T‐lymphocytes in patients with SCIT‐induced granulomas7
Peanut allergen Ara h 6 is detectable in blood transfusion products7
Risk factors of NSAID‐exacerbated respiratory disease: A population‐based study6
6
Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study6
Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment6
Comparison of skin prick test and prick‐to‐prick test with fruits and vegetables in the diagnosis of food allergy6
Issue Information6
Omalizumab prevents respiratory illnesses in non‐atopic chronic spontaneous urticaria patients: A prospective, parallel‐group, pilot pragmatic trial6
Correction to HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) in HLA‐B*58:01 carriers in Korean population; A multicenter cross‐secti6
Efficacy and Safety of Stapokibart in Adults With Moderate‐to‐Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial6
Exercise‐induced eosinophil responses: Normal cell counts with a marked decrease in responsiveness6
10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto6
Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema6
The expression of MUC5AC in patients with rhinosinusitis: A systematic review and meta‐analysis6
Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat6
Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response6
Issue Information6
Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment6
6
Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study6
Novel, computational IgE‐clustering in a population‐based cross‐sectional study: Mapping the allergy burden6
Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma6
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach6
Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence6
Issue Information6
Aeroallergen sensitivity patterns in Gulf countries: A systematic review6
A Multicenter, Randomized, Controlled Clinical Trial on the Efficacy and Safety of Eucalyptol, Limonene, and Pinene Enteric Capsules in the Treatment of Chronic Rhinosinusitis With Nasal Polyps Postop6
0.084156036376953